Patient’s perspective presented by #ZoranaMaravic @digestivecancerseu.bsky.social at #ESMOGI2025 #ESMOAmbassadors @myesmo.bsky.social

@myesmo.bsky.social updated guidelines and living guidelines on #GI cancers presented by #MichelDucreux at #ESMOGI2025 #ESMOAmbassadors

#TeresaMacarulla nicely summarizes new data on #HPB cancers presented at #ESMOGI2025 #HCC #BTC #CCA #PDAC #ESMOAmbassadors @myesmo.bsky.social

#TeresaMacarulla nicely summarizes new data on #HPB cancers presented at #ESMOGI2025 #HCC #BTC #CCA #PDAC #ESMOAmbassadors @myesmo.bsky.social Post n.2

Prof Mazzaferro presents the state of the art of surgery and liver transplant for #HCC in 2025 at #ESMOGI2025 @myesmo.bsky.social #ESMOAmbassadors

Thank you @myesmo.bsky.social #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma
#ESMOAmbassadors
@acpmpresearch.bsky.social

📢 Key takeaways from #ESMOGI2025 on the horizon! Follow us for updates on how research impacts bowel cancer care the work of NBOCA @NATCAN_news @RCS_news @HQIP #NBOCA #BowelCancer

Expert-led Post-#ASCO2025 & #ESMOGI2025 Highlights webinars 💻📍

The #GICancer session will be chaired by
@lorenzarimassa.bsky.social & moderated by Richard Kim, Filippo Pietrantonio & Efrat Dotan

AGENDA 👉 buff.ly/NtN20KG

REGISTER 👉 buff.ly/4Z7VyTB

At #ESMOGI2025, DiCE PAC member Michael Kecht highlighted the worrying surge in early-onset #CRC. He shared patient stories, new research, and the pressing need for earlier diagnosis, personalised care, and stronger patient-clinician partnerships.

➡️ buff.ly/iHxI4ov

Rising Early‑Onset CRC Rates in Asia Underscore Global Trend in Incidence and Need for Coordinated Research Efforts #ESMOGI2025 #crcsm #oncology onclive.com/view/rising-...

Post Hoc Data Highlight Utility of Fruquintinib Across Metastatic Subgroups in Refractory mCRC
#ESMOGI2025 @myesmo.bsky.social #CRCSM
www.onclive.com/view/post-ho...